Desk› Healthcare› Genomic Valley Biotech Ltd
Genomic Valley Biotech Ltd
Filing rhythm · 61 trading days
6 filings · 2 material · busiest 2026-08-14
What it files
Filings
6 in the window
-
17 August 2026
Newspaper PublicationNewspaper Publication
Please find enclosed herewith unaudited financial results for the quarter ended on 30th June, 2026.
Company Update / Newspaper Publication View filing →
-
14 August 2026
Board OutcomeBoard Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Held On Today I.E. 14Th August 2026
Considered and approved the standalone Un-audited financial results of the company for the quarter ended on 30th June 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
14 August 2026
ResultsResults-Financial Results For Quarter Ended On 30 June 2026.
Unaudited financial results for Quarter ended on 30 June 2026.
Result / Financial Results View filing →
-
6 August 2026
Board MeetingBoard Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone) Of The Company For The Quarter Ended On June 30, 2026
Genomic Valley Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve unaudited financial ....
Board Meeting / Board Meeting View filing →
-
6 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on 30th June, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
29 June 2026
Trading WindowClosure of Trading Window
Closure of trading window.
Insider Trading / SAST / Closure of Trading Window View filing →